Start: 09 Nov 2021, 14:30
End: 09 Nov 2021, 15:30

Chair: Ms Zamila Bunglawala, Department of Education, UK
Speaker: Dr Lori Pierce, ASCO Chair of the Board, Professor of Radiation Oncology, University of Michigan, USA
Speaker: Professor Lynn Rochester, Newcastle University, UK
Speaker: Ms Kate Shaw, Innovative Trials, UK
Speaker: Mr Richard Stephens, NCRI Consumer Forum Member, UK

Clinical trials can often lack diversity, not only in terms of race and ethnicity, but also gender, pre-existing health conditions, age and socio-economic factors amongst others. This underrepresentation can become problematic, especially in the context of generalising the results of a study and offering equal opportunities to care for all patients. This session aims to explore the factors that may contribute to the existing issues, how organisations, patients and researchers are trying to solve them and what needs to shift to create a research environment where this is no longer a problem.

By the end of the session, the audience would have understood and appreciated the existing challenges to make clinical trials more equitable, diverse and inclusive and learnt some tangible take-away messages from the panel.

This session is supported by Takeda, however, they have had no input into the content.

Session labels:

Allied Health Professionals Clinical trials Clinicians Live Nurses Panel Patient experts Policy Staff Primary Care Physicians Research Administrators Scientists Students Surgeons Trainees / Early career researchers Treatment